NovoCure Ltd

NVCR

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001917165-26-000004
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026

Summary

Type

Neutral

Net shares

+50,125

% of shares

26.06%

Amount (USD)

$0

Insider confidence score

90.0 out of 100

Positive

  • Massive buy (≥10% of shares)

Negative

  • Minimal buy amount (<$10K)

Stock transactions

Transaction 1

Security

Ordinary Shares

Action

Grant

Date

2026-03-03

Code

A

Net shares

+50,125.0

Acquired/Disposed

Acquired

Shares Owned Before

192,328.0

Shares Owned After

242,453.0

Derivative Transactions

Transaction 1

Security

Stock Option (Right to Buy)

Action

Grant

Date

2026-03-03

Code

A

Net shares

+73,340.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

73,340.0

Filing's footnotes

1. Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates.

2. Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.